Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial

Inhaled antibiotics control chronic airway infection and maintain respiratory health in cystic fibrosis (CF). Given variation in patient responses to inhaled antibiotics, the ability to identify distinct responder phenotypes would facilitate the delivery of personalized care. Previously, a 10-gene p...

Descripción completa

Detalles Bibliográficos
Autores principales: Caceres, Silvia M., Sanders, Linda A., Rysavy, Noel M., Poch, Katie R., Jones, Caroline R., Pickard, Kyle, Fingerlin, Tasha E., Marcus, Roland A., Malcolm, Kenneth C., Taylor-Cousar, Jennifer L., Nichols, David P., Nick, Jerry A., Strand, Matthew, Saavedra, Milene T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070878/
https://www.ncbi.nlm.nih.gov/pubmed/35511761
http://dx.doi.org/10.1371/journal.pone.0267592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070878/
https://www.ncbi.nlm.nih.gov/pubmed/35511761
http://dx.doi.org/10.1371/journal.pone.0267592

Ejemplares similares